|Last Price||Today's Change||52-Week Range||Trading Volume|
|50.37||-0.30 (-0.59%)||36.26 - 54.70||2.0 million (Below Avg)|
Market data as of 1:40PM 04/24/14. Quotes are delayed by at least 15 min.
OncoGenex Announces Fast Track Designation Granted for Custirsen in Combination with Cabazitaxel/Prednisone as Second-line Chemotherapy in Phase 3 AFFINITY Trial of Men with Metastatic Castrate-Resistant Prostate Cancer
04/23/2014 6:00 AM ET
Teva Announces Supreme Court Denial of Request for Interim Relief to Stay Court of Appeals Ruling for COPAXONE® Patent Due to the Potential for the Company to Recover Patent Infringement Damages
04/19/2014 9:40 AM ET